It says a provider can submit additional clinical evidence, cardiovascular risk scores, or metabolic biomarkers such as HbA1c, a lipid panel, or inflammatory markers, and notes many successful appeals document obesity-related comorbidities or diabetes complications the reviewer initially missed
If youve been sticking to the same exercises for a while, your body has likely adapted
Ive done WeightWatchers, the Atkins, those meal replacement shakes Id lose a bit of weight, but then put it back on, she says
Maintenance semaglutide and tirzepatide Weve developed three options for patients that want to keep taking these medications to maintain their weight
That forced Tchang to figure out another treatment plan for several patients, many of whom took Zepbound because it made them less nauseous
doi: 10.1111/jdi.14346 51 Petkovi-DabiJBiniICariBBoiLUmievi-ipkaSBednarukNet al